Unknown

Dataset Information

0

Progression-free survival as a surrogate for overall survival in oncology trials: a methodological systematic review.


ABSTRACT:

Background

Progression-free survival (PFS) is a surrogate endpoint widely used for overall survival (OS) in oncology. Validation of PFS as a surrogate must be done for each indication and each intervention. We aimed to identify all studies evaluating the validity of PFS as a surrogate for OS in oncology, and to describe their methodological characteristics.

Methods

We conducted a systematic review by searching MEDLINE via PubMed and the Cochrane Library with no limitation on time, selected relevant studies and extracted data in duplicate on how surrogacy was evaluated (meta-analytic approach, assessment of correlation and level of evaluation).

Results

We identified 91 studies evaluating the validity of PFS as a surrogate for OS in 24 cancer localisations. Although a meta-analytic approach was used in 83 (91%) studies, the methods used to validate PFS as a surrogate of OS were heterogeneous across studies. Of the 47 studies concluding that PFS is a good surrogate for OS, for 15 (32%), there was no quantitative argument for surrogacy.

Conclusions

Although most studies used a meta-analytic approach as recommended, our methodological review highlights heterogeneity in methods and reporting, which stresses the importance of developing and applying clear recommendations in this area.

SUBMITTER: Belin L 

PROVIDER: S-EPMC7250908 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC6585767 | biostudies-literature
| S-EPMC6080081 | biostudies-literature
| S-EPMC4994928 | biostudies-literature
| S-EPMC7796103 | biostudies-literature
| S-EPMC9239497 | biostudies-literature
| S-EPMC6636299 | biostudies-literature
| S-EPMC6583599 | biostudies-literature
| S-EPMC6991254 | biostudies-literature
| S-EPMC5622859 | biostudies-other
| S-EPMC6503556 | biostudies-literature